Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

ExploNL1 Exploring the role of Neuroligin-1 in synapse formation and function

Coordinator
Centre National De La Recherche Scientifique CNRS, France
Runs
1 September 2024 to 31 August 2026
Status
Running
EU funding
€196k
Total cost
—
Partners
2 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101106943

What the project is doing

In the project's own words, from its summary on CORDIS.

Controlling the precise balance between excitation and inhibition (E/I balance) is critical for information processing in the brain. This equilibrium is regulated at the level of individual synapses, which can be either excitatory or inhibitory depending of the type of neurotransmitter released. It is well established that cell adhesion molecules such as neurexins (NRXs) and neuroligins (NLs) play important roles in synapse formation and specification.

In humans, several genetic mutations in NLs are associated with Autism Spectrum Disorders (ASD) but how those mutations act in the establishment of those disorders remains unclear. One hypothesis is that mutations found in ASD patients can affect the interactions of NLs to specific protein binding partners and/or alter signaling pathways, which could contribute to disrupt the E/I balance. Interestingly, the host group recently discovered a molecular mechanism in which the phosphorylation of unique tyrosine residue located in the intracellular domain of NL1 regulates the differential assembly of excitatory versus inhibitory synapses.

Furthermore, in the absence of highly specific antibodies compatible with immunostaining of native adhesion molecules, little is known about the precise distribution of endogenous NL1 within the synapse. In this project we will #1) decipher the localization of endogenous NL1 and its modulation between excitatory and inhibitory synapses based on its phosphorylation state by using a new transgenic knock-in mouse line in which endogenous NL1 has been tagged with a small biotin acceptor peptide (BAP-NL1)

Topics

Who is involved

OrganisationCityCountryRole
Centre National De La Recherche Scientifique CNRSParisFranceCoordinator
Universite De BordeauxBordeauxFranceAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI